Aurinia Pharmaceuticals auriniapharma.com


Public list: Eye Health (692) Rare Diseases (230)

Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. We are currently developing voclosporin, an investigational drug, for the treatment of lupus nephritis (LN), focal segmental glomerularsclerosis and minimal change disease (MCD). Additionally, we are advancing voclosporin ophthalmic solution (VOS), a topic formulation, for the treatment of dry eye syndrome (DES).

Aurinia is a clinical stage biopharmaceutical company focused on developing and commercializing therapies in disease areas of high unmet medical need. We are currently developing voclosporin, an investigational drug, for the treatment of lupus nephri...Show all

Company (IPO / Went public)

Phone:

Fax:

#1203-4464 Markham Street

Victoria, V8Z 7X8
British Columbia, Canada

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Aurinia Pharmaceuticals $0M Feb 6, 2013

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Aurinia Pharmaceuticals Jobs

jobs by Indeed job
						search
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Cyclosporine analogue mixtures and their use as immunomodulating agents Nov 23, 2015 Sep 19, 2017 Patent
Topical drug delivery systems for ophthalmic use May 05, 2010 Apr 28, 2015 Patent
Cyclosporine analogue mixtures and their use as immunomodulating agents Aug 14, 2017 Application
Topical drug delivery system for ophthalmic use Apr 02, 2015 Application
Ophthalmic compositions Feb 20, 2015 Application
See all 10 patents